Skip to contentG
GRI Bio, Inc.
G
GRIGRI Bio, Inc. Released Aug 10, 2021, before the open
10-Q filed Aug 10, 2021, 41 days after period end · 0001824293-21-000010
Q2 2021 · 10-Q
Revenue$0.00$0.00— vs Q2 2020no prior Q1 2021 on file Net Income-$2.31M-$2.31M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GRI Bio, Inc. · CIK 1824293 · Engraved from SEC EDGAR
N/M vs Q1 2021
EPS Diluted-$0.34-$0.34N/M vs Q2 2020N/M vs Q1 2021 Operating Income-$2,310,000N/M Operating Cash Flowderived-$2,492,000N/M ended Jun 30, 2021 · filed Aug 10, 2021 · 41 d after period end